Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IBS-D (Diarrhea-predominant)”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Not applicableStudy completedNCT05754177
What this trial is testing

Safety and Efficacy of a Probiotic Supplement in IBS-D

Who this might be right for
Irritable Bowel Syndrome With DiarrheaIrritable Bowel Syndrome
The Archer-Daniels-Midland Company 46
Large-scale testing (Phase 3)Ended earlyNCT02239926
What this trial is testing

Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D

Who this might be right for
Diarrhea Predominant Irritable Bowel Syndrome
Mayo Clinic 5
Large-scale testing (Phase 3)Ended earlyNCT01268618
What this trial is testing

Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia

Who this might be right for
IBS-D and Functional Dyspepsia
Sprim Advanced Life Sciences 120
Not applicableStudy completedNCT07520422
What this trial is testing

Bacillus Coagulans Based Product in IBS-Diarrhea

Who this might be right for
IBS-D (Diarrhea-predominant)
Bioagile Therapeutics Pvt. Ltd. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06727422
What this trial is testing

Efficacy of Rifaximin With NAC in IBS-D

Who this might be right for
IBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)
Mark Pimentel, MD 225
Testing effectiveness (Phase 2)Study completedNCT02757105
What this trial is testing

Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
RedHill Biopharma Limited 127
Testing effectiveness (Phase 2)Study completedNCT00230581
What this trial is testing

8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS

Who this might be right for
Irritable Bowel Syndrome
Dynogen Pharmaceuticals 88
Testing effectiveness (Phase 2)Study completedNCT00911612
What this trial is testing

Does Welchol (Colesevelam Hydrochloride) Improve Colonic Transit in Diarrhea-predominant Irritable Bowel Syndrome (D-IBS)?

Who this might be right for
Irritable Bowel SyndromeDiarrhea
Mayo Clinic 24
Not applicableStudy completedNCT06755489
What this trial is testing

Quality of Life in Diarrhea-predominant Irritable Bowel Syndrome Taking GABA

Who this might be right for
Diarrhoea Predominant Irritable Bowel Syndrome
University of Pisa 20
Not applicableStudy completedNCT01257477
What this trial is testing

LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome
Prometheus Laboratories 400
Not applicableLooking for participantsNCT07000383
What this trial is testing

Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome

Who this might be right for
Diarrhea-predominant Irritable Bowel SyndromeIrritable Bowel Syndrome of Diarrhea Type (IBS-D)
University Medical Center Ho Chi Minh City (UMC) 90
Large-scale testing (Phase 3)Study completedNCT01100684
What this trial is testing

Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)

Who this might be right for
Diarrhea Predominant Irritable Bowel Syndrome
Tioga Pharmaceuticals 611
Testing effectiveness (Phase 2)Study completedNCT00394173
What this trial is testing

Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Who this might be right for
Irritable Bowel Syndrome With Diarrhea (IBS-D)
Novartis 180
Post-approval studies (Phase 4)Not Yet RecruitingNCT07574320
What this trial is testing

Effect of Ramosetron in Patients With Diarrhea Predominant Irritable Bowel Syndrome

Who this might be right for
IBS-D (Diarrhea-predominant)
Md. Aminul Islam 76
Not applicableLooking for participantsNCT06681012
What this trial is testing

Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Devintec Sagl 330
Not applicableStudy completedNCT06676514
What this trial is testing

Study to Evaluate the Treatment Benefits of Probiotic Clostridium Butyricum CBM588® for IBS-D

Who this might be right for
IBS-D (Diarrhea-predominant)
Liaquat University of Medical & Health Sciences 405
Testing effectiveness (Phase 2)Ended earlyNCT06153420
What this trial is testing

Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

Who this might be right for
Irritable Bowel Syndrome With Diarrhea
CinPhloro Pharma, LLC 421
Not applicableStudy completedNCT02609529
What this trial is testing

SBI in Children With d-IBS

Who this might be right for
Irritable Bowel Syndrome
Louisiana State University Health Sciences Center in New Orleans 20
Testing effectiveness (Phase 2)Study completedNCT00101725
What this trial is testing

Crofelemer to Treat Diarrhea Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel SyndromeColonic DiseasesDiarrhea+1 more
Bausch Health Americas, Inc. 245
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461
What this trial is testing

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Who this might be right for
Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more
PharmaPlanter Technologies Inc 63
Next Page